Nephros, Inc.NEPHNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank62
5Y CAGR-32.6%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-32.6%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 20252.97%
Q3 20258.20%
Q2 20253.95%
Q1 20255.07%
Q4 20247.93%
Q3 2024-6.43%
Q2 2024-2.77%
Q1 2024-3.75%
Q4 20238.63%
Q3 20235.13%
Q2 2023-4.95%
Q1 2023-0.65%
Q4 2022-2.96%
Q3 2022-24.20%
Q2 2022-3.70%
Q1 2022-12.02%
Q4 2021-0.95%
Q3 2021-0.95%
Q2 20210.31%
Q1 2021-3.10%
Q4 202021.44%
Q3 2020-8.45%
Q2 2020-8.99%
Q1 202057.31%
Q4 20190.65%
Q3 2019-3.83%
Q2 201918.50%
Q1 2019-3.98%
Q4 201812.27%
Q3 201837.38%
Q2 201847.78%
Q1 2018-7.04%
Q4 201776.45%
Q3 2017-0.60%
Q2 2017-13.36%
Q1 201722.44%
Q4 2016-11.03%
Q3 2016-24.66%
Q2 201616.57%
Q1 2016-13.68%